marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-04-2024
AbbVie Balance Sheet 2011-2024 | ABBV
Annual Balance Sheet AbbVie
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
46.6 B | 50.1 B | 54.6 B | 69.1 B | 26.8 B | 33 B | 28.1 B | 31.7 B | 23.3 B | 6.66 B | 5.13 B | 9.77 B | -27.5 M |
Long Term Debt |
59.2 B | 59.1 B | 64.2 B | 77.6 B | 63 B | 35 B | 31 B | 36.4 B | 29.2 B | 10.6 B | 14.3 B | 14.6 B | - |
Long Term Debt Current |
166 M | 166 M | 178 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 81.7 B | 50.6 B | 49 B | 51.7 B | 38.2 B | 14.4 B | 17.8 B | 16.9 B | 1.54 B |
Total Current Liabilities |
37.8 B | 29.5 B | 35.2 B | 28.7 B | 15.6 B | 17.2 B | 16.6 B | 9.78 B | 10.9 B | 11.4 B | 6.88 B | - | - |
Total Liabilities |
- | - | - | - | 97.3 B | 67.8 B | 65.7 B | 61.5 B | 49.1 B | 25.8 B | 24.7 B | 23.6 B | 7.43 B |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1 B | 4.78 B | 3.13 B | 1.06 B | 4.72 B | 3.37 B | 5.46 B | 4.38 B | 2.25 B | 535 M | 1.57 B | - | - |
Total Assets |
135 B | 139 B | 147 B | 151 B | 89.1 B | 59.4 B | 70.8 B | 66.1 B | 53 B | 27.5 B | 29.2 B | 27 B | 19.7 B |
Cash and Cash Equivalents |
12.8 B | 9.2 B | 9.75 B | 8.45 B | 39.9 B | 7.29 B | 9.3 B | 5.1 B | 8.4 B | 8.35 B | 9.6 B | 5.9 B | 27 M |
Book Value |
135 B | 139 B | 147 B | 151 B | -8.17 B | -8.45 B | 5.1 B | 4.64 B | 3.94 B | 1.74 B | 4.49 B | 3.36 B | 12.2 B |
Total Shareholders Equity |
10.4 B | 17.3 B | 15.4 B | 13.1 B | -8.17 B | -8.45 B | 5.1 B | 4.64 B | 3.94 B | 1.74 B | 4.49 B | - | - |
All numbers in USD currency
Quarterly Balance Sheet AbbVie
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
58.5 B | 58 B | 63.8 B | 55.6 B | 55.8 B | 59.3 B | 59.1 B | 60.4 B | - | 63.5 B | 64.2 B | 74 B | 74.2 B | 74.2 B | 84.9 B | 77.6 B | 77.6 B | 77.6 B | 67.2 B | 63 B | 63 B | 63 B | 35 B | 35 B | 35 B | 35 B | 31 B | 31 B | 31 B | 31 B | 36.4 B | 36.4 B | 36.4 B | 36.4 B | 29.2 B | 29.2 B | 29.2 B | 29.2 B | 10.5 B | 10.5 B | 10.5 B | 10.6 B | 14.3 B | 14.3 B | 14.3 B | 14.3 B | 14.6 B | 14.6 B | 14.6 B | 14.6 B | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-4.96 B | -3.77 B | -2.38 B | 933 M | 1.79 B | 2.39 B | 4.78 B | 4.95 B | - | 5.1 B | 3.13 B | 1.6 B | 740 M | 2.29 B | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 4.72 B | 4.72 B | 4.72 B | 4.72 B | 3.37 B | 3.37 B | 3.37 B | 3.37 B | 5.46 B | 5.46 B | 5.46 B | 5.46 B | 4.38 B | 4.38 B | 4.38 B | 4.38 B | 2.25 B | 2.25 B | 2.25 B | 2.25 B | 535 M | 535 M | 535 M | 535 M | 1.57 B | 1.57 B | 1.57 B | 1.57 B | - | - | - | - | - | - | - | - |
Total Assets |
143 B | 142 B | 149 B | 136 B | 135 B | 135 B | 139 B | 141 B | - | 143 B | 147 B | 149 B | 148 B | 151 B | 151 B | 151 B | 151 B | 151 B | 89.1 B | 89.1 B | 89.1 B | 89.1 B | 59.4 B | 59.4 B | 59.4 B | 59.4 B | 70.8 B | 70.8 B | 70.8 B | 70.8 B | 66.1 B | 66.1 B | 66.1 B | 66.1 B | 53 B | 53 B | 53 B | 53 B | 27.5 B | 27.5 B | 27.5 B | 27.5 B | 29.2 B | 29.2 B | 29.2 B | 29.2 B | 27 B | 27 B | 27 B | 27 B | - | - | - | - |
Cash and Cash Equivalents |
7.26 B | 13.1 B | 18.1 B | 13.3 B | 8.76 B | 6.71 B | 9.2 B | 11.8 B | 8.52 B | 6.1 B | 9.75 B | 12.2 B | 8.55 B | 9.76 B | 8.45 B | 8.45 B | 8.45 B | 8.45 B | 39.9 B | 39.9 B | 39.9 B | 39.9 B | 7.29 B | 7.29 B | 7.29 B | 7.29 B | 9.3 B | 9.3 B | 9.3 B | 9.3 B | 5.1 B | 5.1 B | 5.1 B | 5.1 B | 8.4 B | 8.4 B | 8.4 B | 8.4 B | 8.35 B | 8.35 B | 8.35 B | 8.35 B | 9.6 B | 9.6 B | 9.6 B | 9.6 B | 5.9 B | 5.9 B | 5.9 B | 5.9 B | 27 M | - | - | - |
Book Value |
143 B | 142 B | 149 B | 136 B | 135 B | 135 B | 139 B | 141 B | - | 143 B | 147 B | 149 B | 148 B | 151 B | 151 B | 151 B | 151 B | 151 B | 89.1 B | 89.1 B | 89.1 B | 89.1 B | 59.4 B | 59.4 B | 59.4 B | 59.4 B | 70.8 B | 70.8 B | 70.8 B | 70.8 B | 66.1 B | 66.1 B | 66.1 B | 66.1 B | 53 B | 53 B | 53 B | 53 B | 27.5 B | 27.5 B | 27.5 B | 27.5 B | 29.2 B | 29.2 B | 29.2 B | 29.2 B | 27 B | 27 B | 27 B | 27 B | - | - | - | - |
Total Shareholders Equity |
6.03 B | 6.78 B | 8.01 B | 12.1 B | 12.9 B | 13.3 B | 17.3 B | 16 B | 14.7 B | 16.3 B | 15.4 B | 13.6 B | 12.6 B | 13.7 B | 13.1 B | 13.1 B | 13.1 B | 13.1 B | -8.17 B | -8.17 B | -8.17 B | -8.17 B | -8.45 B | -8.45 B | -8.45 B | -8.45 B | 5.1 B | 5.1 B | 5.1 B | 5.1 B | 4.64 B | 4.64 B | 4.64 B | 4.64 B | 3.94 B | 3.94 B | 3.94 B | 3.94 B | 1.74 B | 1.74 B | 1.74 B | 1.74 B | 4.49 B | 4.49 B | 4.49 B | 4.49 B | -350 M | -350 M | -350 M | -350 M | - | - | - | - |
All numbers in USD currency